1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$550,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. Treat and Reduce Obesity Act of 2017 (Bills not introduced 1Q17) Revisions to Medicare reimbursement programs

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2018 (Bills not formally introduced as of filing)

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Regulatory and legislative health care issues impacting pricing and access H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. - Research to Accelerate Cures and Equity (RACE) for Children Act Senate Chronic Disease Initiative Regulatory and legislative health care issues, including the 340B program

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 204 (115th), H.R. 878 (115th), S. 456 (115th), H.R. 1628 (115th)

Budget/Appropriations BUD

Legislation to amend the Affordable Care Act - Addressing pricing and access issues, prescription drug importation, potential reimbursement changes H.R. 1628 - American Health Care Act (AHCA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. Con. Res. 3/H.Res. 48 - To establish the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. S. Amdt. 178 - To amend S. Con. Res 3 to establish a deficit-neutral reserve fund relating to lower prescription drug prices for Americans by importing drugs from Canada

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Res. 48 (115th), H.R. 1628 (115th), S.Con.Res. 3 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.